Skip to main content
SpringerLink
Log in

Ergebnis der TIOSPIR-Studie und deren Auswirkungen auf die Wertigkeit von Metaanalysen

Results of the TIOSPIR study and the effects on the significance of meta-analyses

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bateman ED (2013) Tiotropium Respimat increases the risk of mortality: con. Eur Respir J 42:590–593

    Article  CAS  PubMed  Google Scholar 

  2. Celli B, Decramer M, Kesten S et al (2009) Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180:948–955

    Article  CAS  PubMed  Google Scholar 

  3. Ichinose M, Fujimoto T, Fukuchi Y (2010) Tiotropium 5 µg via Respimat and 18 µg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med 104:228–236

    Article  CAS  PubMed  Google Scholar 

  4. Loke YK, Singh S, Furberg CD (2014) Tiotropium and the risk of death in COPD. N Engl J Med 370:480–481

    Article  CAS  PubMed  Google Scholar 

  5. Noord JA van, Cornelissen PJ, Aumann JL et al (2009) The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir Med 103:22–29

    Article  PubMed  Google Scholar 

  6. Singh S, Loke YK, Enright PL, Furberg CD (2011) Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 342:3215

    Article  Google Scholar 

  7. Tashkin DP, Celli B, Senn S et al (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359:1543–1554

    Article  CAS  PubMed  Google Scholar 

  8. Verhamme KM, Afonso A, Romio S et al (2013) Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD. Eur Respir J 42:606–615

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. N. Waldburg gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Pneumologische Schwerpunktpraxis, Bölschestr. 1a, 30104, Magdeburg, Deutschland

    N. Waldburg

Authors
  1. N. Waldburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Waldburg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Waldburg, N. Ergebnis der TIOSPIR-Studie und deren Auswirkungen auf die Wertigkeit von Metaanalysen. Pneumologe 11, 437–440 (2014). https://doi.org/10.1007/s10405-013-0755-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-013-0755-7

Search

Navigation